Myriad Genetics, Inc. · NASDAQ:MYGN
Raha Samraat S. received 3,542 Myriad Genetics, Inc. shares as an award (Form 4)
Traded Jun 11, 2026 · Filed Jun 12, 2026
On Jun 11, 2026, Raha Samraat S. (Director, President and CEO) received 3,542 Myriad Genetics, Inc. shares as an award at US$3.94 for US$13,955, leaving 1,068,083 shares. Filed Jun 12, 2026 (Form 4).
- Awarded
- 3,542 shares
- Price
- US$3.94
- Value
- US$13,955
- Holding after
- 1,068,083 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Stock | Award | 3,542 | US$3.94 | 1,068,083 | Direct |
Source
Related
- Myriad Genetics, Inc.
- Raha Samraat S.
- Myriad Genetics, Inc. shareholders
- Form 4 · Wheeler Benjamin Richard · Sep 22, 2026
- Form 4 · Sikri Vishal · Sep 17, 2026
- Form 4 · Fox Jennifer Lynne · Sep 8, 2026
- Schedule 13G · BlackRock Portfolio Management LLC · Sep 4, 2026
- Form 4 · Wheeler Benjamin Richard · Aug 17, 2026